Abbott Laboratories (ABT) Reports Mixed Q4 Results

Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.45, $0.01 better than the analyst estimate of $1.44. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.63 billion.

For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand